WHO recommends highly successful COVID-19 therapy and calls for wide geographical distribution and…
Kathmandu: Today, WHO made a strong recommendation for nirmatrelvir and ritonavir, sold under the name Paxlovid, for mild and moderate COVID-19 patients at highest risk of hospital admission, calling it the best therapeutic choice for…
Read More...
Read More...